PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:10 AM ET

Sponsor Check › Person

AC
No photo found yet (own website and image search run after this page is viewed)

Albert Cha

Named as an officer, director or promoter on SEC Form D filings · CA, PA · May 15, 2009 → Jun 30, 2026

19deals (issuers)
$3.87Breported sold
585investors
61Form D filings
2009–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Albert Cha is listed as an executive officer, director, and promoter on 61 SEC Form D filings by 19 issuers between May 2009 and Jun 2026. Largest by amount reported sold: Vivo Capital Fund IX, L.P. (Palo Alto, CA — pooled investment fund — 2018–2019; $1.4B reported sold to 44 investors), Vivo Opportunity Fund, L.P. (Palo Alto, CA — pooled investment fund — 2017–2018; $816.9M reported sold to 81 investors), Vivo Capital Fund VIII, L.P. (Palo Alto, CA — pooled investment fund — 2014–2015; $750M reported sold to 56 investors), Frazier Life Sciences Public Fund, L.P. (Palo Alto, CA — pooled investment fund — 2026; $475.7M reported sold to 142 investors), VYNE Therapeutics Inc. (Bridgewater, NJ — biotechnology — 2017; $88.2M reported sold to 19 investors) and 14 more (all listed below).

What this means That is a lot of deals — 19 separate companies raised money with this person listed as executive officer, director, and promoter, over about 17 years. Across those companies the filings report $3.87B sold in total.

Listed alongside Frank Kung (17 shared filings), David Renzi (13 shared filings), Edgar Engleman (13 shared filings), JAMES GLASHEEN (12 shared filings), David Clapper (11 shared filings) and 106 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Albert. Each name links to their own page.

The issuers belong to 3 sponsor groups: Vivo (21 issuers, $4.22B reported sold, 2011–2026), Ceptaris (2 issuers, $24.1M reported sold, 2009–2012) and Tria (2 issuers, $10M reported sold, 2010–2014).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared the newest 50 of 61 public filings for Albert Cha and found 13 differences, 4 worth asking the sponsor about: Investor count went down between filings; Paid seller listed without a CRD number: China Concept Consulting Ltd; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Albert Cha has not run yet — it is joining a line of 8,759 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Albert Cha..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

13 differences found between the filings for Albert Cha — 4 worth asking about (compared the newest 50 of 61 filings on Oct 24, 2026; older filings not covered)

Worth asking · Aug 14, 2017 – Aug 13, 2018

Investor count went down between filings — Aclaris Therapeutics, Inc.

The Aug 14, 2017 filing reports 42 investors; the Aug 13, 2018 Form D/A reports 41 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Aug 14, 2017 ↗Form D/A (later) · Aug 13, 2018 ↗Aclaris Therapeutics, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jan 23, 2019 – Oct 30, 2019

Paid seller listed without a CRD number: China Concept Consulting Ltd. — Vivo Capital Fund IX, L.P.

China Concept Consulting Ltd. is listed as receiving sales compensation on 4 filings (Jan 23, 2019 to Oct 30, 2019) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D/A · Oct 30, 2019 ↗BrokerCheck search: China Concept Consulting Ltd. ↗Vivo Capital Fund IX, L.P. — PartnerFacts page ↗
Sources
Worth asking · Sep 14, 2011 – Jan 8, 2016

6 Form Ds were filed more than 15 days after the first sale

Form D filed 125 days after the first sale — AIRXPANDERS INC · Form D filed 286 days after the first sale — TRIA Beauty, Inc. · Form D filed 68 days after the first sale — TRIA Beauty, Inc. · Form D filed 16 days after the first sale — MINERVA SURGICAL INC · Form D filed 35 days after the first sale — TRIA Beauty, Inc. · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Jun 8, 2015 ↗AIRXPANDERS INC — PartnerFacts page ↗Form D · Sep 2, 2014 ↗TRIA Beauty, Inc. — PartnerFacts page ↗
Sources
Worth asking · Aug 14, 2017 – Aug 13, 2018

Albert Cha is no longer listed on the Aug 13, 2018 amendment — Aclaris Therapeutics, Inc.

Albert Cha appears on the Aug 14, 2017 Form D (director) but not on the Aug 13, 2018 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D · Aug 14, 2017 ↗Form D/A · Aug 13, 2018 ↗Albert Cha — PartnerFacts page ↗Aclaris Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jan 30, 2012 – Oct 30, 2019

5 offerings changed their target amount between filings

Offering amount changed between filings — Vivo Capital Fund IX, L.P. · Offering amount changed between filings — Vivo Capital Fund VIII, L.P. · Offering amount changed between filings — Vivo Capital Fund VIII, L.P. · Offering amount changed between filings — AIRXPANDERS INC · Offering amount changed between filings — AIRXPANDERS INC

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Aug 12, 2019 ↗Form D/A (later) · Oct 30, 2019 ↗Vivo Capital Fund IX, L.P. — PartnerFacts page ↗Form D/A (earlier) · Feb 5, 2015 ↗
Sources
Note · Jul 14, 2011 – May 26, 2020

20 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — MINERVA SURGICAL INC (latest filing May 26, 2020) · No amendment in the last 12 months on an offering that may still be open — MINERVA SURGICAL INC (latest filing Dec 4, 2019) · No amendment in the last 12 months on an offering that may still be open — MINERVA SURGICAL INC (latest filing May 16, 2019) · No amendment in the last 12 months on an offering that may still be open — Vivo Opportunity Co-Invest (W), L.P. (latest filing May 8, 2019) · No amendment in the last 12 months on an offering that may still be open — Vivo Opportunity Co-Invest, L.P. (latest filing Apr 19, 2019) · and 15 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · May 26, 2020 ↗MINERVA SURGICAL INC — PartnerFacts page ↗Form D · Dec 4, 2019 ↗Form D · May 16, 2019 ↗
Sources
Note · Sep 22, 2014 – Dec 27, 2016

Industry group changed between filings — MINERVA SURGICAL INC

"Other" (Sep 22, 2014 to Jan 8, 2016); then "Other Health Care" (Dec 27, 2016 to May 26, 2020).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Sep 22, 2014 ↗Form D · Dec 27, 2016 ↗MINERVA SURGICAL INC — PartnerFacts page ↗
Sources
Note · Dec 9, 2014

Same name, different state: "Albert Cha" (G7) is a separate record

This page covers filings where the address state is CA or PA. A separate record, "Albert Cha" with address state G7, is listed on 1 filing — most recently by Ascendis Pharma A/S (Dec 9, 2014). Both records have filings in the same period (Dec 9, 2014).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Albert Cha (G7) — PartnerFacts page ↗Form D · Dec 9, 2014 ↗Ascendis Pharma A/S — PartnerFacts page ↗Albert Cha (CA,PA) — this page ↗
Sources
Note · May 1, 2014

Same name, different state: "Albert Cha" (MI) is a separate record

This page covers filings where the address state is CA or PA. A separate record, "Albert Cha" with address state MI, is listed on 1 filing — most recently by ProNAi Therapeutics Inc (May 1, 2014). Both records have filings in the same period (May 1, 2014).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Albert Cha (MI) — PartnerFacts page ↗Form D · May 1, 2014 ↗ProNAi Therapeutics Inc — PartnerFacts page ↗Albert Cha (CA,PA) — this page ↗
Sources
Note · Dec 4, 2019 – May 26, 2020

Address moved from Redwood City, CA to Santa Clara, CA — MINERVA SURGICAL INC

The people listed on the Dec 4, 2019 filing give Redwood City, CA; on the May 26, 2020 filing they give Santa Clara, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Dec 4, 2019 ↗Form D · May 26, 2020 ↗MINERVA SURGICAL INC — PartnerFacts page ↗
Sources
Note · Aug 14, 2017 – Aug 13, 2018

Address moved from Malvern, PA to Wayne, PA — Aclaris Therapeutics, Inc.

The people listed on the Aug 14, 2017 filing give Malvern, PA; on the Aug 13, 2018 filing they give Wayne, PA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Aug 14, 2017 ↗Form D/A · Aug 13, 2018 ↗Aclaris Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jan 3, 2011 – Jun 30, 2026

Albert Cha is listed with 2 different address states: CA, PA

CA on 48 filings (Jan 3, 2011 to Jun 30, 2026); PA on 3 filings (Sep 11, 2015 to Aug 14, 2017).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jan 3, 2011 ↗Form D · Sep 11, 2015 ↗
Sources
Note · Sep 10, 2012 – Oct 8, 2014

Reported revenue range changed between filings — Aclaris Therapeutics, Inc.

"No Revenues" (Sep 10, 2012); then "Decline to Disclose" (Oct 8, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Sep 10, 2012 ↗Form D · Oct 8, 2014 ↗Aclaris Therapeutics, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 61 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

3 of 44 offerings report sales commissions totalling $13,353,637; 0 report finder's fees; 6 report proceeds to related persons totalling $13,945,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jun 30, 2026 D
Frazier Life Sciences Public Fund, L.P.
File 021-589142
$0 (est.)$0$0
The general partner is entitled to a performance allocation. The investment manager is entitled to a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials.
XT CAPITAL PARTNERS, LLC BrokerCheck CRD 118719 ↗EDGAR ↗
May 26, 2020 D
MINERVA SURGICAL INC
File 021-367681
$0$0$0None listed on this filingEDGAR ↗
Dec 4, 2019 D
MINERVA SURGICAL INC
File 021-354743
$0$0$0None listed on this filingEDGAR ↗
Oct 30, 2019 D/A
Vivo Capital Fund IX, L.P.
File 021-319413
$10,321,136$0$0Probitas Funds Group, LLC BrokerCheck CRD 115876 ↗
via Probitas Funds Group, LLC (CRD 115876 ↗)

China Concept Consulting Ltd. no CRD number reported
Gold Eagle Enterprises Limited BrokerCheck CRD 677370 ↗
Goldman Sachs & Co. LLC BrokerCheck CRD 361 ↗
via Goldman Sachs & Co. LLC (CRD 361 ↗)

XT Capital Partners, LLC BrokerCheck CRD 118719 ↗
via XT Capital Partners, LLC (CRD 118719 ↗)
EDGAR ↗
Sep 27, 2019 D
Vivo Capital Fund IX E&F, L.P.
File 021-349902
$0$0$0None listed on this filingEDGAR ↗
May 16, 2019 D
MINERVA SURGICAL INC
File 021-339780
$0$0$0None listed on this filingEDGAR ↗
May 8, 2019 D
Vivo Opportunity Co-Invest (W), L.P.
File 021-339110
$0$0$0None listed on this filingEDGAR ↗
Apr 19, 2019 D
Vivo Opportunity Co-Invest, L.P.
File 021-337704
$0$0$0None listed on this filingEDGAR ↗
Jan 4, 2019 D
MINERVA SURGICAL INC
File 021-329621
$0$0$0None listed on this filingEDGAR ↗
Aug 31, 2018 D/A
Vivo Opportunity Fund, L.P.
File 021-301674
$1,732,500$0$0XT Capital Partners, LLC BrokerCheck CRD 118719 ↗
via XT Capital Partners, LLC (CRD 118719 ↗)
EDGAR ↗
Mar 13, 2018 D
MINERVA SURGICAL INC
File 021-307556
$0$0$0None listed on this filingEDGAR ↗
Aug 14, 2017 D
Aclaris Therapeutics, Inc.
File 021-292766
$0$0$0None listed on this filingEDGAR ↗
Jul 28, 2017 D
VYNE Therapeutics Inc.
File 021-291729
$0$0$0None listed on this filingEDGAR ↗
Dec 27, 2016 D
MINERVA SURGICAL INC
File 021-277087
$0$0$0None listed on this filingEDGAR ↗
Jun 14, 2016 D
Aclaris Therapeutics, Inc.
File 021-264946
$1,300,001$0$0William Blair & Company L.L.C. BrokerCheck CRD 1252 ↗
Guggenheim Securities, LLC BrokerCheck CRD 40638 ↗		EDGAR ↗
Jan 8, 2016 D
MINERVA SURGICAL INC
File 021-254790
$0$0$0None listed on this filingEDGAR ↗
Sep 11, 2015 D
Aclaris Therapeutics, Inc.
File 021-247471
$0$0$1,800,000 (est.)None listed on this filingEDGAR ↗
Jun 8, 2015 D
AIRXPANDERS INC
File 021-241294
$0$0$0
Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.
None listed on this filingEDGAR ↗
Mar 18, 2015 D/A
Vivo Capital Fund VIII, L.P.
File 021-230367
$0$0$0
The investors are obligated to pay a management fee to the General Partner (or an affiliate thereof).
None listed on this filingEDGAR ↗
Mar 5, 2015 D
Carbylan Therapeutics, Inc.
File 021-235286
$0$0$0None listed on this filingEDGAR ↗
Oct 14, 2014 D
Carbylan Therapeutics, Inc.
File 021-226318
$0$0$0None listed on this filingEDGAR ↗
Oct 9, 2014 D
TRIA Beauty, Inc.
File 021-226145
$0$0$0None listed on this filingEDGAR ↗
Oct 8, 2014 D
Aclaris Therapeutics, Inc.
File 021-226021
$0$0$1,800,000 (est.)None listed on this filingEDGAR ↗
Sep 22, 2014 D
MINERVA SURGICAL INC
File 021-225123
$0$0$0None listed on this filingEDGAR ↗
Sep 10, 2014 D/A
AIRXPANDERS INC
File 021-198238
$0$0$0
Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.
None listed on this filingEDGAR ↗
Sep 2, 2014 D
TRIA Beauty, Inc.
File 021-223941
$0$0$0None listed on this filingEDGAR ↗
May 21, 2014 D
TRIA Beauty, Inc.
File 021-217766
$0$0$0None listed on this filingEDGAR ↗
Jun 3, 2013 D
TRIA Beauty, Inc.
File 021-197368
$0$0$0None listed on this filingEDGAR ↗
Jan 3, 2013 D
Carbylan Therapeutics, Inc.
File 021-189403
$0$0$0 (est.)None listed on this filingEDGAR ↗
Dec 3, 2012 D
TRIA Beauty, Inc.
File 021-187755
$0$0$0None listed on this filingEDGAR ↗
Sep 10, 2012 D
Aclaris Therapeutics, Inc.
File 021-183855
$0$0$3,600,000 (est.)None listed on this filingEDGAR ↗
May 22, 2012 D
CEPTARIS THERAPEUTICS, INC
File 021-178599
$0$0$3,200,000 (est.)None listed on this filingEDGAR ↗
May 18, 2012 D/A
AIRXPANDERS INC
File 021-172629
$0$0$0
Proceeds will be used for general corporate purposes including, but not limited to, executive salaries
None listed on this filingEDGAR ↗
Apr 30, 2012 D
Medley Health, Inc.
File 021-177441
$0$0$0None listed on this filingEDGAR ↗
Jan 3, 2012 D
Vivo Ventures VII Affiliates Fund, L.P.
File 021-171042
$0$0$0
The investors are obligated to pay a management fee to the General Partner (or an affiliate thereof).
None listed on this filingEDGAR ↗
Dec 20, 2011 D
TRIA Beauty, Inc.
File 021-170345
$0$0$0None listed on this filingEDGAR ↗
Oct 27, 2011 D
Medley Health, Inc.
File 021-167881
$0$0$0None listed on this filingEDGAR ↗
Sep 6, 2011 D/A
Vivo Ventures Fund VII, L.P.
File 021-152838
$0$0$0
The investors are obligated to pay a management fee to the General Partner(s) (or an affiliate thereof).
None listed on this filingEDGAR ↗
Aug 17, 2011 D
CEPTARIS THERAPEUTICS, INC
File 021-164580
$0$0$3,000,000 (est.)None listed on this filingEDGAR ↗
Jul 29, 2011 D
NEOMEND INC
File 021-163709
$0$0$0None listed on this filingEDGAR ↗
Feb 10, 2011 D/A
TRIA Beauty, Inc.
File 021-147043
$0$0$0None listed on this filingEDGAR ↗
Sep 15, 2010 D
Medley Health, Inc.
File 021-147795
$0$0$0None listed on this filingEDGAR ↗
Jun 29, 2010 D/A
Vicept Therapeutics, Inc.
File 021-133791
$0$0$545,000 (est.)None listed on this filingEDGAR ↗
Feb 8, 2010 D
NEOMEND INC
File 021-41537
$0$0$0
The proceeds are being used for working capital.
None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 19

Every issuer that named Albert Cha on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

FL
Pooled Investment Fund

Frazier Life Sciences Public Fund, L.P.

Palo Alto, CA · Jun 30, 2026
  • Jun 30, 2026 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer, Promoter (Managing Member of the GP of the GP of the Issuer) EDGAR ↗

Raised $475.7M from 142 investors as of the latest filing. Albert is listed as executive officer, promoter.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

MS
Other Health Care

MINERVA SURGICAL INC

Santa Clara, CA · Sep 22, 2014 → May 26, 2020 · 8 filings
  • May 26, 2020 · D · $15,000,000 sold of $30,000,000 · 14 investors · min. $1 · role: Director EDGAR ↗
  • Dec 4, 2019 · D · $10,000,000 sold of $10,500,000 · 16 investors · min. $1 · role: Director EDGAR ↗
  • May 16, 2019 · D · $10,228,734 sold of $10,500,000 · 25 investors · min. $1 · role: Director EDGAR ↗
  • Jan 4, 2019 · D · $9,200,757 sold of $10,000,000 · 17 investors · min. $1 · role: Director EDGAR ↗
  • Mar 13, 2018 · D · $10,000,000 sold of $20,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 27, 2016 · D · $16,723,237 sold of $26,723,235 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 8, 2016 · D · $15,000,000 sold of $15,000,000 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 22, 2014 · D · $25,519,660 sold of $25,525,500 · 26 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $26.2M from 26 investors (87% of the $30M target) as of the latest filing. Albert is listed as director on 8 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VC
Pooled Investment Fund · group: Vivo

Vivo Capital Fund IX, L.P.

Palo Alto, CA · Aug 16, 2018 → Oct 30, 2019 · 6 filings
  • Oct 30, 2019 · D/A · $1,401,787,761 sold of $1,401,787,761 · 44 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Aug 12, 2019 · D/A · $1,304,978,261 sold of Indefinite · 38 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Jun 3, 2019 · D/A · $1,280,978,261 sold of Indefinite · 36 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Jan 23, 2019 · D/A · $863,978,261 sold of Indefinite · 29 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Dec 6, 2018 · D/A · $863,978,261 sold of Indefinite · 29 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Aug 16, 2018 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗

Raised $1.4B from 44 investors (100% of the $1.4B target) as of the latest filing. Albert is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VC
Pooled Investment Fund · group: Vivo

Vivo Capital Fund IX E&F, L.P.

Palo Alto, CA · Sep 27, 2019
  • Sep 27, 2019 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Albert is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VO
Pooled Investment Fund · group: Vivo

Vivo Opportunity Co-Invest (W), L.P.

Palo Alto, CA · May 8, 2019
  • May 8, 2019 · D · $20,000,000 sold of Indefinite · 3 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

Raised $20M from 3 investors as of the latest filing. Albert is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VO
Pooled Investment Fund · group: Vivo

Vivo Opportunity Co-Invest, L.P.

Palo Alto, CA · Apr 19, 2019
  • Apr 19, 2019 · D · $80,000,000 sold of Indefinite · 1 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

Raised $80M from 1 investor as of the latest filing. Albert is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VO
Pooled Investment Fund · group: Vivo

Vivo Opportunity Fund, L.P.

Palo Alto, CA · Dec 26, 2017 → Aug 31, 2018 · 2 filings
  • Aug 31, 2018 · D/A · $634,625,000 sold of Indefinite · 40 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP.) EDGAR ↗
  • Dec 26, 2017 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP.) EDGAR ↗

Raised $816.9M from 81 investors as of the latest filing. Albert is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Pharmaceuticals

Aclaris Therapeutics, Inc.

Wayne, PA · Sep 10, 2012 → Aug 14, 2017 · 5 filings
  • Aug 14, 2017 · D · $10,000,000 sold of $12,500,000 · 42 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 14, 2016 · D · $20,000,017 sold of $20,000,017 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 11, 2015 · D · $40,000,000 sold of $40,000,000 · 28 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 8, 2014 · D · $10,644,244 sold of $21,288,488 · 25 investors · min. $4,786 · role: Director EDGAR ↗
  • Sep 10, 2012 · D · $20,890,000 sold of $20,890,000 · 31 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $80M from 42 investors (100% of the $12.5M target) as of the latest filing. Albert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VT
Pharmaceuticals

VYNE Therapeutics Inc.

Bridgewater, NJ · Jul 28, 2017
  • Jul 28, 2017 · D · $50,500,001 sold of $50,500,001 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $88.2M from 19 investors (100% of the $50.5M target) as of the latest filing. Albert is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Other Health Care

AIRXPANDERS INC

Palo Alto, CA · Jan 30, 2012 → Jun 8, 2015 · 5 filings
  • Jun 8, 2015 · D · $2,996,635 sold of $5,030,235 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 10, 2014 · D/A · $9,949,305 sold of $10,050,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 19, 2013 · D · $4,287,807 sold of $9,045,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 18, 2012 · D/A · $11,387,690 sold of $11,387,690 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 30, 2012 · D · $10,307,690 sold of $11,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $14.9M from 34 investors (100% of the $5.03M target) as of the latest filing. Albert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VC
Pooled Investment Fund · group: Vivo

Vivo Capital Fund VIII, L.P.

Palo Alto, CA · Dec 18, 2014 → Mar 18, 2015 · 3 filings
  • Mar 18, 2015 · D/A · $750,000,000 sold of $750,000,000 · 56 investors · min. No minimum reported · role: Director (A Managing Member of the General Partner) EDGAR ↗
  • Feb 5, 2015 · D/A · $600,650,000 sold of $600,650,000 · 43 investors · min. No minimum reported · role: Director (A Managing Member of the General Partner) EDGAR ↗
  • Dec 18, 2014 · D · $427,650,000 sold of $427,650,000 · 33 investors · min. No minimum reported · role: Director (A Managing Member of the General Partner) EDGAR ↗

Raised $750M from 56 investors (100% of the $750M target) as of the latest filing. Albert is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Other Health Care

Carbylan Therapeutics, Inc.

Palo Alto, CA · Jan 3, 2013 → Mar 5, 2015 · 3 filings
  • Mar 5, 2015 · D · $4,000,000 sold of $4,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 14, 2014 · D · $5,000,000 sold of $5,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 3, 2013 · D · $5,999,999 sold of $13,228,600 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 4 investors (100% of the $4M target) as of the latest filing. Albert is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TB
Other Health Care · group: Tria

TRIA Beauty, Inc.

Dublin, CA · Aug 27, 2010 → Oct 9, 2014 · 9 filings
  • Oct 9, 2014 · D · $8,501,700 sold of Indefinite · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 2, 2014 · D · $2,992,007 sold of $2,992,007 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 21, 2014 · D · $13,501,350 sold of $15,001,500 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 3, 2013 · D · $40,525,143 sold of Indefinite · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 3, 2012 · D · $7,500,863 sold of $20,002,300 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 20, 2011 · D · $20,000,003 sold of $20,000,003 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 10, 2011 · D/A · $26,271,203 sold of $26,271,203 · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 1, 2010 · D/A · $20,958,804 sold of $20,958,804 · 36 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 27, 2010 · D · $15,611,572 sold of $15,611,572 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $40.5M from 38 investors as of the latest filing. Albert is listed as director on 9 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CT
Pharmaceuticals · group: Ceptaris

CEPTARIS THERAPEUTICS, INC

Malvern, PA · Aug 17, 2011 → May 22, 2012 · 2 filings
  • May 22, 2012 · D · $8,292,176 sold of $10,000,000 · 33 investors · min. $185 · role: Director EDGAR ↗
  • Aug 17, 2011 · D · $8,150,000 sold of $8,150,000 · 30 investors · min. $12,400 · role: Director EDGAR ↗

Raised $8.29M from 33 investors (83% of the $10M target) as of the latest filing. Albert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

MH
Other Health Care · group: Tria

Medley Health, Inc.

Dublin, CA · Sep 15, 2010 → Apr 30, 2012 · 3 filings
  • Apr 30, 2012 · D · $1,500,000 sold of $1,500,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 27, 2011 · D · $3,999,999 sold of $3,999,999 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 15, 2010 · D · $7,500,000 sold of $7,500,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7.5M from 4 investors (100% of the $1.5M target) as of the latest filing. Albert is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

VV
Pooled Investment Fund · group: Vivo

Vivo Ventures VII Affiliates Fund, L.P.

Palo Alto, CA · Jan 3, 2012
  • Jan 3, 2012 · D · $6,375,000 sold of $6,375,000 · 31 investors · min. No minimum reported · role: Director (A Managing Member of the General Partner) EDGAR ↗

Raised $6.38M from 31 investors (100% of the $6.38M target) as of the latest filing. Albert is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

VV
Pooled Investment Fund · group: Vivo

Vivo Ventures Fund VII, L.P.

Palo Alto, CA · Jan 3, 2011 → Sep 6, 2011 · 2 filings
  • Sep 6, 2011 · D/A · $0 sold of $350,000,000 · 0 investors · min. No minimum reported · role: Director (A Managing Member of the General Partners) EDGAR ↗
  • Jan 3, 2011 · D · $0 sold of $350,000,000 · 0 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Albert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

N
Other Health Care

NEOMEND INC

Irvine, CA · May 15, 2009 → Jul 29, 2011 · 5 filings
  • Jul 29, 2011 · D · $10,000,000 sold of $20,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 8, 2010 · D · $33,123,888 sold of $33,123,888 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 14, 2009 · D · $3,000,000 sold of $3,899,092 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 13, 2009 · D · $0 sold of $120,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 15, 2009 · D · $2,702,727 sold of $3,512,727 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $33.1M from 15 investors (100% of the $20M target) as of the latest filing. Albert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

VT
Pharmaceuticals · group: Ceptaris

Vicept Therapeutics, Inc.

Malvern, PA · Aug 20, 2009 → Jun 29, 2010 · 2 filings
  • Jun 29, 2010 · D/A · $15,790,501 sold of $15,790,501 · 12 investors · min. $10,000 · role: Director EDGAR ↗
  • Aug 20, 2009 · D · $6,257,000 sold of $12,514,000 · 8 investors · min. $10,000 · role: Director EDGAR ↗

Raised $15.8M from 12 investors (100% of the $15.8M target) as of the latest filing. Albert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Albert Cha — MI, 1 issuer, May 1, 2014 → May 1, 2014 · no shared issuer
  • Albert Cha — Denmark (as filed: G7), 1 issuer, Dec 9, 2014 → Dec 9, 2014 · no shared issuer

People around Albert 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

VC
Management entity

Vivo Capital IX, LLC

Promoter · 6 shared filings (1 issuer)

Listed on the same filings as Albert Cha. Their page shows their other deals.

VO
Management entity

Vivo Opportunity, LLC

Promoter · 4 shared filings (3 issuers) · also on 3 other issuers

Vivo Opportunity, LLC is on 6 issuers in total — a repeat sponsor. Their page lists every one.

VV
Management entity

Vivo Ventures VII, LLC

Director, Promoter · 3 shared filings (2 issuers)

Listed on the same filings as Albert Cha. Their page shows their other deals.

VC
Management entity

Vivo Capital VIII, LLC

Promoter · 3 shared filings (1 issuer)

Listed on the same filings as Albert Cha. Their page shows their other deals.

VC
Management entity

Vivo Capital IX (Cayman), LLC

Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Albert Cha. Their page shows their other deals.

FK
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Kung

Director, Executive Officer · 17 shared filings (8 issuers) · also on 16 other issuers

Frank Kung is on 24 issuers in total — a repeat sponsor. Their page lists every one.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

David Renzi

Executive Officer, Director · 13 shared filings (3 issuers)

Listed on the same filings as Albert Cha. Their page shows their other deals.

EE
No photo found yet (own website and image search run after this page is viewed)
Person

Edgar Engleman

Director, Executive Officer · 13 shared filings (5 issuers) · also on 10 other issuers

Edgar Engleman is on 15 issuers in total — a repeat sponsor. Their page lists every one.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

JAMES GLASHEEN

Director · 12 shared filings (2 issuers)

Listed on the same filings as Albert Cha. Their page shows their other deals.

SF
No photo found yet (own website and image search run after this page is viewed)
Person

Shan Fu

Executive Officer, Director · 11 shared filings (5 issuers) · also on 6 other issuers

Shan Fu is on 11 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David Clapper

Director, Executive Officer · 11 shared filings (3 issuers) · also on 4 other issuers

David Clapper is on 7 issuers in total — a repeat sponsor. Their page lists every one.

KA
No photo found yet (own website and image search run after this page is viewed)
Person

KEVIN J. APPELBAUM

Director, Executive Officer · 11 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Albert Cha. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

David Mauney

Director · 9 shared filings (1 issuer) · also on 10 other issuers

David Mauney is on 11 issuers in total — a repeat sponsor. Their page lists every one.

TI
No photo found yet (own website and image search run after this page is viewed)
Person

TOBIN C. ISLAND

Executive Officer · 9 shared filings (1 issuer)

Listed on the same filings as Albert Cha. Their page shows their other deals.

SE
No photo found yet (own website and image search run after this page is viewed)
Person

STEVE ELMS

Director · 9 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Albert Cha. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Rodney Perkins

Director · 8 shared filings (1 issuer) · also on 6 other issuers

Rodney Perkins is on 7 issuers in total — a repeat sponsor. Their page lists every one.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Bruno Strul

Director, Executive Officer · 8 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Albert Cha. Their page shows their other deals.

HL
No photo found yet (own website and image search run after this page is viewed)
Person

HARVEY LIU

Executive Officer · 8 shared filings (1 issuer)

Listed on the same filings as Albert Cha. Their page shows their other deals.

RJ
No photo found yet (own website and image search run after this page is viewed)
Person

Ross Jaffe

Director · 8 shared filings (1 issuer) · also on 12 other issuers

Ross Jaffe is on 13 issuers in total — a repeat sponsor. Their page lists every one.

CY
No photo found yet (own website and image search run after this page is viewed)
Person

Chen Yu

Director, Executive Officer · 7 shared filings (2 issuers) · also on 9 other issuers

Chen Yu is on 11 issuers in total — a repeat sponsor. Their page lists every one.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David C. Auth

Director · 7 shared filings (1 issuer) · also on 4 other issuers

David C. Auth is on 5 issuers in total — a repeat sponsor. Their page lists every one.

ST
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Tullman

Director, Executive Officer · 7 shared filings (3 issuers) · also on 8 other issuers

Stephen Tullman is on 11 issuers in total — a repeat sponsor. Their page lists every one.

NW
No photo found yet (own website and image search run after this page is viewed)
Person

Neal Walker

Executive Officer, Director · 7 shared filings (2 issuers) · also on 4 other issuers

Neal Walker is on 6 issuers in total — a repeat sponsor. Their page lists every one.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Powala

Executive Officer · 7 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Albert Cha. Their page shows their other deals.

CT
No photo found yet (own website and image search run after this page is viewed)
Person

Csaba Truckai

Director · 7 shared filings (1 issuer) · also on 6 other issuers

Csaba Truckai is on 7 issuers in total — a repeat sponsor. Their page lists every one.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Ali Behbahani

Director · 7 shared filings (1 issuer) · also on 25 other issuers

Ali Behbahani is on 26 issuers in total — a repeat sponsor. Their page lists every one.

MV
No photo found yet (own website and image search run after this page is viewed)
Person

MICHAEL VALENTINO

Director · 7 shared filings (1 issuer)

Listed on the same filings as Albert Cha. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Anand Mehra

Director · 6 shared filings (2 issuers) · also on 6 other issuers

Anand Mehra is on 8 issuers in total — a repeat sponsor. Their page lists every one.

KJ
No photo found yet (own website and image search run after this page is viewed)
Person

Kamil Ali-Jackson

Executive Officer · 6 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Albert Cha. Their page shows their other deals.

TS
No photo found yet (own website and image search run after this page is viewed)
Person

Tadmor Shalon

Director · 5 shared filings (1 issuer) · also on 4 other issuers

Tadmor Shalon is on 5 issuers in total — a repeat sponsor. Their page lists every one.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Barry Cheskin

Executive Officer, Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Albert Cha. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Alex Barkas

Director · 5 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Albert Cha. Their page shows their other deals.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Jack B. Nielsen

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Albert Cha. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy Mills

Director · 5 shared filings (1 issuer) · also on 6 other issuers

Timothy Mills is on 7 issuers in total — a repeat sponsor. Their page lists every one.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brigitte Smith

Director · 5 shared filings (1 issuer) · also on 6 other issuers

Brigitte Smith is on 7 issuers in total — a repeat sponsor. Their page lists every one.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Dodson

Executive Officer, Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Albert Cha. Their page shows their other deals.

EU
No photo found yet (own website and image search run after this page is viewed)
Person

EDWARD UNKART

Director · 5 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Albert Cha. Their page shows their other deals.

FR
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Ruffo

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Albert Cha. Their page shows their other deals.

The team behind the deals

V
Sponsor group

Vivo

21 issuers · 41 filings · $4.22B reported sold · 2011–2026

One team, 21 deal companies. Albert Cha is listed on 8 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Albert Cha.

C
Sponsor group

Ceptaris

2 issuers · 6 filings · $24.1M reported sold · 2009–2012

One team, 2 deal companies. Albert Cha is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Albert Cha.

T
Sponsor group

Tria

2 issuers · 12 filings · $10M reported sold · 2010–2014

One team, 2 deal companies. Albert Cha is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Albert Cha.

Same business address

30 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 19 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Albert Cha by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 19 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Albert Cha is listed on: none on file. No website or social profile named in Vivo Capital Fund VIII, L.P.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #306,270 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Palo Alto, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Pennsylvania UJS portal case search ↗New Jersey state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Pennsylvania Secretary of State business search ↗New Jersey Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Albert Cha appears on a new Form D, or when a court case or SEC action is matched to them. See plans →